Omalizumab decreases exacerbation frequency, oral intake of corticosteroids and peripheral blood eosinophils in atopic patients with uncontrolled asthma. (Q50990133)
Jump to navigation
Jump to search
scientific article published in December 2011
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Omalizumab decreases exacerbation frequency, oral intake of corticosteroids and peripheral blood eosinophils in atopic patients with uncontrolled asthma. |
scientific article published in December 2011 |
Statements
Omalizumab decreases exacerbation frequency, oral intake of corticosteroids and peripheral blood eosinophils in atopic patients with uncontrolled asthma (English)
G Pelaia
L Gallelli
P Romeo
T Renda
M T Busceti
A Proietto
S A Marsico